A Study of Cobimetinib in Combination With Paclitaxel as First-line Treatment for Patients With Metastatic Triple-negative Breast Cancer

Clinical Trial ID NCT02322814

PubWeight™ 1.63^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02322814

Top papers